Aldosterone in uremia: beyond blood pressure
Aldosterone was in the past considered only as a prohypertensinogenic agent. It has recently become clear that apart from the classical endocrine action, i.e. causing blood pressure elevation as a result of salt retention, aldosterone has numerous blood-pressure-independent actions on nonepithelial...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 08 2010
|
| In: |
Blood purification
Year: 2010, Jahrgang: 29, Heft: 2, Pages: 111-113 |
| ISSN: | 1421-9735 |
| DOI: | 10.1159/000245635 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000245635
|
| Verfasserangaben: | Eberhard Ritz, Nadezda Koleganova |
| Zusammenfassung: | Aldosterone was in the past considered only as a prohypertensinogenic agent. It has recently become clear that apart from the classical endocrine action, i.e. causing blood pressure elevation as a result of salt retention, aldosterone has numerous blood-pressure-independent actions on nonepithelial tissue. Under conditions of high salt concentration, aldosterone is injurious to the kidney, heart and vasculature. Of particular interest are recent observations that aldosterone is a permissive factor for the effect of minor increases in plasma sodium concentration on endothelial cell dysfunction. Despite surprising effects of aldosterone blockade on blood pressure of anuric dialysis patients, the potential role of mineralocorticoid receptor blockade in dialysis patients is currently unclear and requires controlled investigation to define the risk of potential hazards, specifically hyperkalemia. |
|---|---|
| Beschreibung: | Gesehen am 24.05.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 1421-9735 |
| DOI: | 10.1159/000245635 |